195
Views
3
CrossRef citations to date
0
Altmetric
Meta-analysis

Outcomes of Transradial Versus Transfemoral Access of Percutaneous Coronary Intervention in STEMI: Systematic Review and Updated Meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 433-444 | Received 18 Nov 2020, Accepted 08 Apr 2021, Published online: 28 Apr 2021

References

  • O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;61(4):e78–e140.
  • Manoukian SV, Voeltz MD, Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Clin Cardiol. 2007;30(S2):II-24-II-34.
  • Howe MJ, Seth M, Riba A, et al. Underutilization of radial access in patients undergoing percutaneous coronary intervention for ST-segment–elevation myocardial infarction: insights from the blue cross blue shield of Michigan cardiovascular consortium. Circulation: Cardiovasc Interventions. 2015;8(5):e002036.
  • Mason PJ, Shah B, Tamis-Holland JE, et al. An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American heart association. Circulation: Cardiovasc Interventions. 2018;11(9):e000035.
  • Valgimigli M, Gagnor A, Calabró P, et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385(9986):2465–2476.
  • Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (radial versus femoral randomized investigation in ST-elevation acute coronary syndrome) study. J Am Coll Cardiol. 2012;60(24):2481–2489.
  • Hamon M, Pristipino C, Di Mario C, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European association of percutaneous cardiovascular interventions and working groups on acute cardiac care** and thrombosis of the European society of cardiology. EuroIntervention. 2013;8(11):1242–1251.
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315.
  • Singh S, Singh M, Grewal N, et al. Transradial vs transfemoral percutaneous coronary intervention in st-segment elevation myocardial infarction: a systemic review and meta-analysis. Can J Cardiol. 2016;32(6):777–790.
  • Pang J, Zhang Z, Yang YJ, et al. The efficacy and safety of transradial percutaneous coronary intervention vs transfemoral percutaneous coronary intervention for ST-segment elevation myocardial infarction patients: a meta-analysis. Int J Cardiol. 2014;177(2):483–488.
  • Ferrante G, Rao SV, Jüni P, et al. Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials. JACC Cardiovasc Interv. 2016;9(14):1419–1434.
  • Megaly M, Karatasakis A, Abraham B, et al. Radial versus femoral access in chronic total occlusion percutaneous coronary intervention. Circ Cardiovasc Interv. 2019;12(6):e007778.
  • Basu D, Singh PM, Tiwari A, et al. Meta-analysis comparing radial versus femoral approach in patients 75 years and older undergoing percutaneous coronary procedures. Indian Heart J. 2017;69(5):580–588.
  • Le May M, Wells G, So D, et al. Safety and efficacy of femoral access vs radial access in st-segment elevation myocardial infarction: the SAFARI-STEMI randomized clinical trial. JAMA Cardiol. 2020;5(2):126–134.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.
  • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Turner L, Boutron I, Hróbjartsson A, et al. The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the cochrane collaboration. Syst Rev. 2013;2(79). DOI:10.1186/2046-4053-2-79
  • Ruano-Ravina A, Aldama-López G, Cid-Álvarez B, et al. Radial vs femoral access after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Thirty-day and one-year mortality results. Rev Esp Cardiol (Engl Ed). 2013;66(11):871–878.
  • Bagai J, Hess E, Penny WF, et al. Outcomes of transradial PCI compared to transfemoral PCI in veterans with anemia: Insight from the VA clinical assessment, reporting and tracking (CART) program. Cardiovasc Revasc Med. 2019;20(11):990–996.
  • Mehta SR, Jolly SS, Cairns J, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60(24):2490–2499.
  • Bernat I, Horak D, Stasek J, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63(10):964–972.
  • Brasselet C, Tassan S, Nazeyrollas P, et al. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart. 2007;93(12):1556–1561.
  • Chodór P, Kurek T, Kowalczuk A, et al. Radial vs femoral approach with StarClose clip placement for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. RADIAMI II: a prospective, randomised, single centre trial. Kardiol Pol. 2011;69(8):763–771.
  • Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction–the RADIAL-AMI pilot randomized trial. Am Heart J. 2005;150(3):543–549.
  • Arzamendi D, Ly HQ, Tanguay JF, et al. Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2010;106(2):148–154.
  • Blake SR, Shahzad A, Aggarwal SK, et al. Radial versus femoral vascular access in ST-elevation myocardial infarction: are the results of femoral operators unfairly represented in observational research? Am Heart J. 2019;210(81–87):81–87.
  • Chung S, Yang JH, Choi SH, et al. Transradial versus transfemoral intervention for the treatment of left main coronary bifurcations: results from the COBIS (COronary BIfurcation Stenting) II Registry. J Invasive Cardiol. 2015;27(1):35–40.
  • Choe JC, Cha KS, Choi JH, et al. Comparison of frequency of bleeding and major adverse cardiac events after transradial versus transfemoral intervention in the recent antiplatelet era. Am J Cardiol. 2016;117(10):1588–1595.
  • De Maria GL, Burzotta F, Trani C, et al. Trends and outcomes of radial approach in left-main bifurcation percutaneous coronary intervention in the drug-eluting stent era: a two-center registry. J Invasive Cardiol. 2015;27(7):E125–136.
  • Díaz de la llera LS, Fournier Andray JA, Gómez Moreno S. [Transradial approach for percutaneous coronary stenting in the treatment of acute myocardial infarction] Rev Esp Cardiol. 2004;57(8):732–736.
  • Sciahbasi A, Burzotta F, Rigattieri S, et al. Impact of vascular approach (transradial vs. transfemoral) on the efficacy of thrombus aspiration in acute myocardial infarction patients. Cardiovasc Revasc Med. 2012;13(2):79–83.
  • Siudak Z, Zawislak B, Dziewierz A, et al. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry. Coron Artery Dis. 2010;21(5):292–297.
  • Gellen B, Lesault PF, Canouï-Poitrine F, et al. Feasibility limits of transradial primary percutaneous coronary intervention in acute myocardial infarction in the real life (TRAP-AMI). Int J Cardiol. 2013;168(2):1056–1061.
  • Hsueh SK, Hsieh YK, Wu CJ, et al. Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenoses: transradial versus transfemoral approach. Chang Gung Med J. 2008;31(2):190–200.
  • Hu F, Yang Y, Qiao S, et al. Comparison between radial and femoral approach for percutaneous coronary intervention in patients aged 80 years or older. J Interv Cardiol. 2012;25(5):513–517.
  • Ibebuogu UN, Cercek B, Makkar R, et al. Comparison between transradial and transfemoral percutaneous coronary intervention in acute ST-elevation myocardial infarction. Am J Cardiol. 2012;110(9):1262–1265.
  • Jaffe R, Hong T, Sharieff W, et al. Comparison of radial versus femoral approach for percutaneous coronary interventions in octogenarians. Catheter Cardiovasc Interv. 2007;69(6):815–820.
  • Kajiya T, Agahari F, Wai KL, et al. A single-center experience of transitioning from a routine transfemoral to a transradial intervention approach in ST-elevation myocardial infarction: impact on door-to-balloon time and clinical outcomes. J Cardiol. 2013;62(1):12–17.
  • Kedev S, Sukmawan R, Kalpak O, et al. Transradial versus transfemoral access for female patients who underwent primary PCI in STEMI: two years follow-up data from acute STEMI interventional registry. Int J Cardiol. 2016;217(Suppl):S16–20.
  • Kim JY, Yoon J, Jung HS, et al. Feasibility of the radial artery as a vascular access route in performing primary percutaneous coronary intervention. Yonsei Med J. 2005;46(4):503–510.
  • Koutouzis M, Matejka G, Olivecrona G, et al. Radial vs. femoral approach for primary percutaneous coronary intervention in octogenarians. Cardiovasc Revasc Med. 2010;11(2):79–83.
  • Li H, Rha SW, Choi BG, et al. Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population. Korean J Intern Med. 2018;33(4):716–726.
  • Philippe F, Larrazet F, Meziane T, et al. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab. Catheter Cardiovasc Interv. 2004;61(1):67–73.
  • Zhang Q, Qiu JP, Zhang RY, et al. Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban. Chin Med J (Engl). 2013;126(6):1063–1068.
  • Schussler JM, Vasudevan A, Von Bose LJ, et al. Comparative efficacy of transradial versus transfemoral approach for coronary angiography and percutaneous coronary intervention. Am J Cardiol. 2016;118(4):482–488.
  • Secco GG, Marinucci L, Uguccioni L, et al. Transradial versus transfemoral approach for primary percutaneous coronary interventions in elderly patients. J Invasive Cardiol. 2013;25(5):254–256.
  • Tomassini F, Gagnor A, Montali N, et al. Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population. Cardiovasc Revasc Med. 2013;14(4):193–196.
  • Valsecchi O, Musumeci G, Vassileva A, et al. Safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction. Ital Heart J. 2003;4(5):329–334.
  • Yamashita Y, Shiomi H, Morimoto T, et al. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry. Heart Vessels. 2017;32(12):1448–1457.
  • Yang YJ, Kandzari DE, Gao Z, et al. Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes. JACC Cardiovasc Interv. 2010;3(10):1035–1042.
  • Weaver AN, Henderson RA, Gilchrist IC, et al. Arterial access and door-to-balloon times for primary percutaneous coronary intervention in patients presenting with acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2010;75(5):695–699.
  • Ziakas A, Klinke P, Mildenberger R, et al. Comparison of the radial and femoral approaches in left main PCI: a retrospective study. J Invasive Cardiol. 2004;16(3):129–132.
  • Schernthaner C, Hammerer M, Harb S, et al. Radial versus femoral access site for percutaneous coronary intervention in patients suffering acute myocardial infarction: a randomized prospective multicenter trial. Wien Klin Wochenschr. 2018;130(5–6):182–189.
  • Généreux P, Mehran R, Palmerini T, et al. Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. EuroIntervention. 2011;7(8):905–916.
  • Achenbach S, Ropers D, Kallert L, et al. Transradial versus transfemoral approach for coronary angiography and intervention in patients above 75 years of age. Catheter Cardiovasc Interv. 2008;72(5):629–635.
  • Bhat FA, Changal KH, Raina H, et al. Transradial versus transfemoral approach for coronary angiography and angioplasty - A prospective, randomized comparison. BMC Cardiovasc Disord. 2017;17(1):23.
  • Chodór P, Krupa H, Kurek T, et al. RADIal versus femoral approach for percutaneous coronary interventions in patients with Acute Myocardial Infarction (RADIAMI): a prospective, randomized, single-center clinical trial. Cardiol J. 2009;16(4):332–340.
  • Hetherington SL, Adam Z, Morley R, et al. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart. 2009;95(19):1612–1618.
  • Hou L, Wei YD, Li WM, et al. Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction. Saudi Med J. 2010;31(2):158–162.
  • Yip HK, Chung SY, Chai HT, et al. Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience. Circ J. 2009;73(11):2050–2055.
  • Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409–1420.
  • Kołtowski Ł, Filipiak KJ, Kochman J, et al. Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMI - Randomized, control trial. Hellenic J Cardiol. 2016;57(3):198–202.
  • Louvard Y, Benamer H, Garot P, et al. Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study). Am J Cardiol. 2004;94(9):1177–1180.
  • Pancholy S, Patel T, Sanghvi K, et al. Comparison of door-to-balloon times for primary PCI using transradial versus transfemoral approach. Catheter Cardiovasc Interv. 2010;75(7):991–995.
  • Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv. 2003;59(1):26–33.
  • Wang YB, Fu XH, Wang XC, et al. Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis. J Invasive Cardiol. 2012;24(8):412–416.
  • Yan ZX, Zhou YJ, Zhao YX, et al. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction. Chin Med J (Engl). 2008;121(9):782–786.
  • Hess CN, Peterson ED, Neely ML, et al. The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the national cardiovascular data registry. Circulation. 2014;129(22):2277–2286.
  • Ball WT, Sharieff W, Jolly SS, et al. Characterization of operator learning curve for transradial coronary interventions. Circ Cardiovasc Interv. 2011;4(4):336–341.
  • Valgimigli M, Frigoli E, Leonardi S, et al. Bivalirudin or unfractionated heparin in acute coronary syndromes. N Engl J Med. 2015;373(11):997–1009.
  • Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol. 2009;53(22):2019–2027.
  • Rao SV, O’Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96(9):1200–1206.
  • Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114(8):774–782.
  • Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol. 2007;49(12):1362–1368.
  • Lee MS, Wolfe M, Stone GW. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence. JACC Cardiovasc Interv. 2013;6(11):1149–1152.
  • Sweis RN. Comparing percutaneous coronary intervention access sites for ST-elevation myocardial infarction-are radial and femoral access equally safe? JAMA Cardiol. 2020;5(2):134–135.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.